Nausea from weed
Pro Research Analysisby 
Searched over 200M research papers
Nausea from Weed: Insights from Recent Research
Cannabis Use and Nausea in Pregnancy
Increased Nausea and Vomiting in Pregnant Women Using Cannabis
Research indicates that cannabis use during pregnancy is associated with an increased likelihood of experiencing moderate-to-severe nausea and vomiting. A study involving 9,250 participants found that those with detectable levels of THC-COOH in their urine had higher odds of severe nausea compared to those without detectable levels. Another study corroborated these findings, showing that prenatal marijuana use was more prevalent among women who reported severe nausea during pregnancy.
Cannabinoid Hyperemesis Syndrome (CHS)
Cannabinoid Hyperemesis Syndrome (CHS) is a condition characterized by chronic cannabis use leading to cyclic episodes of nausea, vomiting, and abdominal pain, which are often relieved by hot baths. This syndrome is frequently underdiagnosed, especially in pregnant women, due to its similarity to hyperemesis gravidarum . Recognizing CHS is crucial for timely and effective treatment, which primarily involves cessation of cannabis use.
Cannabis as an Antiemetic for Chemotherapy-Induced Nausea
Efficacy of Cannabinoids in Reducing Chemotherapy-Induced Nausea
Cannabis-based medications, particularly those containing delta-9-tetrahydrocannabinol (THC), have been shown to be effective in reducing nausea and vomiting induced by chemotherapy. Studies have demonstrated that patients receiving THC experienced significant reductions in vomiting compared to those receiving a placebo . However, the use of cannabinoids is often limited by their side effects, such as dizziness, euphoria, and dysphoria.
Pharmacokinetics and Pharmacodynamics of Oral Cannabinoids
Oral cannabinoids, such as dronabinol and nabilone, have been used to treat chemotherapy-induced nausea and vomiting. These medications have shown similar or improved efficacy compared to conventional antiemetics. However, they exhibit high pharmacokinetic variability, which can affect their overall effectiveness and safety profile.
Trends and Self-Reported Efficacy of Cannabis for Nausea
Trends in Prenatal Marijuana Use
The prevalence of prenatal marijuana use has remained elevated over time among women with nausea and vomiting in pregnancy (NVP). Data from a large healthcare system showed that the adjusted prevalence of marijuana use increased significantly from 2009 to 2016 among women with NVP. This trend underscores the need for healthcare providers to inquire about marijuana use and offer evidence-based treatments for NVP.
Self-Reported Efficacy of Cannabis for Morning Sickness
A survey of medicinal cannabis users revealed that a significant number of women used cannabis to alleviate pregnancy-induced nausea and vomiting. Among those who used cannabis for this purpose, over 92% rated it as "extremely effective" or "effective". These findings highlight the potential of cannabis as a therapeutic option, although further research is needed to fully understand its safety and efficacy.
Conclusion
The relationship between cannabis use and nausea is complex and multifaceted. While cannabis and its derivatives have shown promise in reducing nausea and vomiting, particularly in chemotherapy patients, their use during pregnancy is associated with increased risks of severe nausea and vomiting. Additionally, chronic cannabis use can lead to Cannabinoid Hyperemesis Syndrome, a condition that requires cessation of cannabis for symptom relief. As trends in marijuana use continue to evolve, especially among pregnant women, it is crucial for healthcare providers to stay informed and offer appropriate guidance and treatment options.
Sources and full results
Most relevant research papers on this topic